Bronchitis, Chronic Clinical Trial
Official title:
A Multicenter, Multinational, Randomized, DB Controlled Study of the Efficacy & Safety of Oral Telithromycin 800 mg Once QD for 5 Days vs Azithromycin in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPD.
Non-inferiority efficacy of telithromycin versus azithromycin
Status | Completed |
Enrollment | 668 |
Est. completion date | September 2004 |
Est. primary completion date | September 2004 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 45 Years and older |
Eligibility |
Inclusion Criteria: - Adult outpatients, either sex, aged 45 years or older. - Patients with a documented history of chronic bronchitis with a basal FEV1 <70% and >35% made in the previous 12 months and who had had at least one or more AEBC in the previous year and with FEV1/FVC <70% (lung function tests made in the previous 12 months). - Patients with a clinical diagnosis of acute exacerbation of chronic bronchitis presumably due to bacterial infection based on all of the following signs and symptoms of AECB: increased sputum purulence, and at least 1 of the 2 following signs and symptoms (increased dyspnea, increased sputum volume). - Patients with negative chest radiography (posterior/anterior and lateral views) to rule out a pneumonia within 48 hours before initiation of study medication or at the latest 24 hours after initiation of study medication (it was necessary to not include patients with pneumonia associated with AECB). - Patients with sputum specimens collected at inclusion for gram stain and bacteriological culture. The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial. |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Sanofi |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Principal efficacy criterion: clinical outcome - Main secondary efficacy criteria: - Bacteriological response at TOC visit; - Time to relapse up to 6 months after inclusion. | At TOC visit (Day 17-Day 21). |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT00245453 -
Outpatient Registry Trial of Respiratory Tract Infections in Adults
|
Phase 4 | |
Completed |
NCT00473460 -
Intermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic Bronchitis
|
Phase 3 | |
Completed |
NCT00649831 -
A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic Bronchitis
|
Phase 3 | |
Completed |
NCT01507415 -
Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD?
|
N/A | |
Active, not recruiting |
NCT00608764 -
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
|
||
Completed |
NCT02637219 -
Innate Immune Response in COPD
|
N/A | |
Completed |
NCT00406705 -
The Effect of Breathing Helium-Hyperoxia During Pulmonary Rehabilitation in Patients With COPD
|
Phase 2 | |
Completed |
NCT00257140 -
A Study of the Safety and Effectiveness of Levofloxacin Compared With Cefaclor in the Treatment of Adults With Chronic Bronchitis Experiencing Rapid Onset of Worsening of Symptoms Caused by Bacteria
|
Phase 2/Phase 3 | |
Completed |
NCT01719822 -
Physical Activity Augmentation Using Pedometers During Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
|
N/A | |
Terminated |
NCT02261350 -
Post-hospitalisation Nutritional Support and Gait Speed in COPD
|
Phase 3 | |
Completed |
NCT01495780 -
eRT Remote Health Monitoring
|
N/A | |
Completed |
NCT01077102 -
Eccentric Exercise Training as Novel Rehabilitation for Chronic Obstructive Pulmonary Disease (COPD)
|
N/A | |
Terminated |
NCT00288223 -
Telithromycin in Acute Exacerbation of Chronic Bronchitis
|
Phase 4 | |
Completed |
NCT00644449 -
A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Acute Symptoms of Chronic Bronchitis
|
Phase 3 | |
Completed |
NCT00423137 -
Effect of BIBW 2948 BS in COPD
|
Phase 2 | |
Completed |
NCT02483637 -
Safety and Feasibility Study of Rejuvenairâ„¢ for Treating Chronic Bronchitis Patients
|
N/A | |
Completed |
NCT00932802 -
Greatest International Antiinfective Trial With Avelox
|
N/A | |
Completed |
NCT00245427 -
Outcomes of Patients Not Responding to Antibiotics in the Community
|
N/A | |
Completed |
NCT00035828 -
A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD
|
Phase 2 | |
Completed |
NCT00184977 -
COPD on Primary Care Treatment (COOPT)
|
Phase 4 |